Pharma CBD Cannabinoid Research

Pharma CBD Research Dashboard

Loading research dashboard…

Loading Primary Studies…

Loading Related Studies…

Overview - Pharma CBD

Description of Pharma CBD

Pharmacologically produced products containing CBD correspond to a cannabis chemotype III. They represent a class of drugs that are produced and standardized from either man-made or plant-based materials.


The Federal Drug Administration (FDR) approved (June 25, 2018) a pharmaceutical version of CBD (Epidiolex) for marketing in the treatment of a couple of rare pediatric seizure disorders (Lennox-Gastaut syndrome and Dravet sundrome).

Other Names:

Pharmaceutical CBD

Epidiolex, Cannabidiol, (-)-Cannabidiol, (-)-trans-Cannabidiol


IUPAC Name: 2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol


Molecular Formula: C21H30O2


Source– PubChem

Pharma CBD Properties and Effects

Only Members can view Properties and Effects information. See DEMO page.

Pharma CBD Receptor Binding

Only Members can view Receptor Binding information. See DEMO page.

Disclaimer
Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own licensed physician or other medical professional. You should not use the information contained herein for diagnosing or treating a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.

Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.